As of 2025, the FDA’s AI and Machine Learning in Medical Devices Program reports over 900 active submissions leveraging AI for clinical or regulatory evidence generation i.e., a 60% increase year over year. Still, few organizations have the data maturity or governance models to scale safely. This session explores where Gen AI is already proving value—and what scientific and operational guardrails leaders must build to turn innovation into sustainable advantage
Our long-standing clients include some of the worlds leading brands and forward-thinking corporations.